Pharmaceutical Quality (Industry)
1.0.0 - STU1 International flag

This page is part of the Pharmaceutical Quality (Industry) (v1.0.0: STU1) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version. For a full list of available versions, see the Directory of published versions

: Composition - Drug - example, risk - XML Representation

Raw xml | Download



<Composition xmlns="http://hl7.org/fhir">
  <id value="composition-drug-pq-risk"/>
  <!--     Based on Accumulus FHIR Product Example - Drug Product  -->
  <meta>
    <profile
             value="http://hl7.org/fhir/uv/pharm-quality/StructureDefinition/Composition-drug-pq"/>
  </meta>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: Composition</b><a name="composition-drug-pq-risk"> </a><a name="hccomposition-drug-pq-risk"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Composition &quot;composition-drug-pq-risk&quot; </p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-Composition-drug-pq.html">Composition - Drug PQ</a></p></div><p><b>status</b>: final</p><p><b>type</b>: Product Note - Summary for Risk of Impurities <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> ()</span></p><p><b>date</b>: 2023-10-01</p><p><b>author</b>: <a href="Organization-organization-drug-pq-ex1.html">Organization/organization-drug-pq-ex1</a> &quot;AAA Molybdenum Products, Inc.&quot;</p><p><b>title</b>: 3.2.P.2.2.4 - Summary for Risk of Impurities</p></div>
  </text>
  <status value="final"/>
  <type>
    <text value="Product Note - Summary for Risk of Impurities"/>
  </type>
  <subject>🔗 
    <reference
               value="MedicinalProductDefinition/medicinalproductdefinition-drug-product-pq-ex1"/>
  </subject>
  <date value="2023-10-01"/>
  <author>🔗 
    <reference value="Organization/organization-drug-pq-ex1"/>
  </author>
  <title value="3.2.P.2.2.4 - Summary for Risk of Impurities"/>
  <section>
    <text>
      <status value="additional"/>
      <div xmlns="http://www.w3.org/1999/xhtml">
                <p>Text for the risk assessment of elemental impurities in the product</p>
            </div>
    </text>
  </section>
</Composition>